Results from study of tusamitamab ravtansine vs. docetaxel in previously treated advanced non-squamous NSCLC
by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainA Phase III study comparing tusamitamab ravtansine with docetaxel in patients with advanced non-squamous non-s
Updated on: September 25,2024
0

Results from study of tusamitamab ravtansine vs. docetaxel in previously treated advanced non-squamous NSCLC
by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainA Phase III study comparing tusamitamab ravtansine with docetaxel in patients with advanced non-squamous non-s
Updated on:September 25,2024
0
